Your browser doesn't support javascript.
loading
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
Schifanella, Luca; Barnett, Susan W; Bissa, Massimiliano; Galli, Veronica; Doster, Melvin N; Vaccari, Monica; Tomaras, Georgia D; Shen, Xiaoying; Phogat, Sanjay; Pal, Ranajit; Montefiori, David C; LaBranche, Celia C; Rao, Mangala; Trinh, Hung V; Washington-Parks, Robyn; Liyanage, Namal P M; Gorini, Giacomo; Brown, Dallas R; Liang, Frank; Loré, Karin; Venzon, David J; Magnanelli, William; Metrinko, Michelle; Kramer, Josh; Breed, Matthew; Alter, Galit; Ruprecht, Ruth M; Franchini, Genoveffa.
Afiliação
  • Schifanella L; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Barnett SW; Novartis Vaccines and Diagnostics, Inc, Cambridge, Massachusetts, United States of America.
  • Bissa M; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Galli V; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Doster MN; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Vaccari M; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Tomaras GD; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
  • Shen X; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
  • Phogat S; Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America.
  • Pal R; Advanced BioScience Laboratories, Inc., Rockville, Maryland, United States of America.
  • Montefiori DC; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
  • LaBranche CC; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
  • Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Trinh HV; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Washington-Parks R; U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
  • Liyanage NPM; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Gorini G; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Liang F; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Loré K; Karolinska Institute, Stockholm, Sweden.
  • Venzon DJ; Karolinska Institute, Stockholm, Sweden.
  • Magnanelli W; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Metrinko M; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
  • Kramer J; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
  • Breed M; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
  • Alter G; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.
  • Ruprecht RM; Ragon Institute of MGH, MIT, and Harvard Cambridge, Boston, Massachusetts, United States of America.
  • Franchini G; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
PLoS Pathog ; 15(12): e1008121, 2019 12.
Article em En | MEDLINE | ID: mdl-31794588
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Vacinas contra a SAIDS / Compostos de Alúmen / Anticorpos Neutralizantes Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Vacinas contra a SAIDS / Compostos de Alúmen / Anticorpos Neutralizantes Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article